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Summary
Background: Elderly ICU patients with multiple organ dysfunction syndrome (MODS) have a high
risk of death therefore early detection is critical for an improved prognosis. The performance of current
scoring systems used to assess the severity of MODS lack sufficient sensitivity and specificity to
accurately guide clinicians’ actions. This study aims to develop an interpretable and generalizable
model with superior performance for early mortality prediction in elderly patients with MODS.
Methods: The MIMIC-III, eICU-CRD and PLAGH-S databases (with 57,786, 200,859 and 1,462
unique ICU admissions, respectively) were employed for model generation and evaluation. We used the
machine learning model XGBoost (eXtreme Gradient Boosting) with the SHapley Additive
exPlanations method to conduct early and interpretable predictions of patients’ hospital outcome. Three
types of data source combinations (from single center, multicenter and the fusion of both) and five
typical evaluation indexes (AUC, sensitivity, specificity, F1 and accuracy) were adopted to develop a
generalizable model.
Findings: The interpretable model, with optimal performance developed by using MIMIC-III and
eICU-CRD datasets, was separately validated in MIMIC-III, eICU-CRD and PLAGH-S datasets (no
overlapping with training set). The performances of the model in predicting hospital mortality as
validated by the three datasets were: AUC of 0·858, sensitivity of 0·834 and specificity of 0·705; AUC
of 0·849, sensitivity of 0·763 and specificity of 0·784; and AUC of 0·838, sensitivity of 0·882 and
specificity of 0·691, respectively. Comparisons of AUC (95% CI) between this model and baseline
models with MIMIC-III dataset validation showed superior performances of this model (0·858 [0·841 -
0·875] vs. 0·854 [0·838 - 0·871], 0·834 [0·817 - 0·853], 0·824 [0·804 - 0·844], 0·788 [0·766 - 0·810]
and 0·741 [0·716 - 0·765] compared with LR, NN, SVM, RF and NB, respectively); In addition,
comparisons in AUC between this model and commonly used clinical scores showed significantly
better performance of this model (0·858 [0·841 - 0·875] vs. 0·752 [0·729 - 0·776], 0·73 [0·704 -
0·757], 0·694 [0·669 - 0·719], 0·686 [0·659 - 0·713] and 0·668 [0·639 - 0·697] compared with OASIS,
APSIII, MODS, SAPS and SOFA, respectively).
Interpretation: The interpretable machine learning model developed in this study using fused datasets
with large sample sizes was robust and generalizable. This model outperformed the baseline models
and several clinical scores for early prediction of mortality in elderly ICU patients. The interpretative
nature of this model provided clinicians with the ranking of mortality risk features and the rationale for
assessing the patient’s mortality risk probability.
2Introduction
Multiple organ dysfunction syndrome (MODS) is a continuous process with physiologic
derangement in more than one organ,1 and its leading culprits include infection, injury, hypoperfusion
and hypermetabolism status, etc..2 The high morbidity and mortality, as well as the substantial medical
expenses in patients who are admitted to intensive care unit (ICU) and encounter MODS, have been a
very challenging issue.1,3 It should be noted that elderly patients (≥ 65 years old) with MODS have a
significantly higher mortality risk compared with younger patients due to their fragile health status and
potential comorbidities.4,5 A prior study reported that the mortality risk in elderly patients suffering
from multiple organ (over three) failure could be up to 50% ~ 100%.6 Moreover, even if they survived,
the need for long-term clinical care and organ function support treatment would be a heavy financial
burden that is hardly bearable.7,8 Therefore, early assessment of organ failure severity and mortality
prediction in elderly patients with MODS are of vital importance in giving clinicians more time to
respond by providing individualized clinical and nursing care.
Since 1980, extensive studies on clinical scores evaluating the risk of death based on patient’s
organ function or severity of illness have been carried out. These include the Acute Physiology and
Chronic Health Evaluation-II (APACHE-II) score established by Knaus et al,9 followed by the
modified score of the APACHE III prognostic system developed in 1991,10 Simplified Acute
Physiology Score (SAPS II) including 17 variables (19 variables in the APACHE-III) in assessing the
severity of organ failure proposed by Le Gall et al,11 Multiple organ dysfunction score (MODS) by
Marshall et al,12 and the widely recognized Sequential Organ Failure Assessment (SOFA) score
developed by Vincent et al.13 However, a growing body of literature has demonstrated that the scores
mentioned above failed to accurately assess and predict the risk of death14 for the following reasons: 1)
the factors and their assigned weights according to a panel of experts’ experience could not fully reflect
the characteristic of a larger population;15,16 2) the individual linear addition of each organ system could
not represent the complex situation and the intrinsic correlations of organ systems;16 and 3) they were
not adequately calibrated in multicenter and large sample cohorts.15
Recently, the availability of electronic health records (EHR) data has allowed researchers to focus
on developing machine learning algorithms for powerful analysis of complex and heterogeneous data
and sophisticated modeling capacity.17 The OASIS severity score, designed by Johnson et.al, was a
novel illness scale using part of the variables from APACHE-III and particle swarm optimization
algorithm to achieve an effective prediction of mortality and length of hospitalization.18 The Super ICU
Learner Algorithm (SICULA) was proposed by Romain et al to improve mortality prediction,15 which
adopted an ensemble machine learning method with a better predictive performance than those
obtained from scoring systems. However, these scores or algorithms focus solely on adult ICU patients
and lack sufficient samples for external validation of the model. Specifically, SICULA can only provide
clinicians with risk probability but not the rationale for the assessment. Targeting this, Benjamin et. al
developed an acuity assessing score, DeepSOFA, using deep learning methods.19 With the same
elements as a SOFA score, it was more optimal in evaluating disease severity by providing clinicians
with a more accurate mortality prediction than its predecessor. However, it only included limited
information without exploring other potentially meaningful factors for diagnosis. Meanwhile, the
model was developed based on a local database and validated in a public single-center database from
the same country, without further analysis on how to get a robust and universal prediction model. A
Meyer et. al also employed deep learning methods to develop a real-time model of serious
complications including mortality.20 While it performed well, it is a black box to clinicians. Moreover,
3so far, few research studies focusing on elderly patients with MODS have been conducted.
In this paper, we aim to develop a prediction model to assist clinicians in the early diagnosis and
treatment of this specific elderly population admitted to the ICU. With rigorous methodology, we
propose an efficient way to acquire a robust and generalizable model, which is then validated in
multicenter and cross-country datasets (developed: US, developing: China) with large sample sizes.
The assessment of the degree of nervous system damage, as indicated in Glasgow coma score (GCS),
was found to deserve more attention from clinicians. Likewise, two important risk factors, blood urea
nitrogen (BUN) and shock index (SI), which are largely ignored in current commonly-used clinical
scores, were identified to be highly relevant to patient mortality. The proposed model with
interpretability can help clinicians better understand the decision-making process in the assessment of
disease severity and take full advantage of any opportunities for early intervention.
Methods
We performed a longitudinal, multicenter, retrospective study based on three high-volume
databases, including the Medical Information Mart for Intensive Care Database v1·4 (MIMIC-III),21,22
eICU Collaborative Research Database v1·2 (eICU-CRD) and PLAGH Surgical Intensive Care
Database v1·1 (PLAGH-S).23
Data Sources
MIMIC-III is a large, open-access, single-center dataset of 38,605 deidentified ICU patients who
were admitted to the Beth Israel Deaconess Medical Center between 2002 and 2012. eICU-CRD is a
multi-center, telehealth ICU and freely available dataset including over 200,000 de-identified ICU
admissions covering 208 Critical Care Units in the United States from 2014 and 2015. PLAGH-S is a
surgical ICU database under development from the General Hospital of the People’s Liberation Army
(PLAGH), a tertiary hospital integrating high-level education and research in China. We utilized data
from 1,102 patients in 2017 and 2018, in which the identification information of patients was removed
similar to the MIMIC-III database. These three databases (MIMIC-III, eICU-CRD and PLAGH-S)
contain all medical records of patients during their ICU stay, typically including demographic
information, vital signs, laboratory tests, medications, diagnoses, orders, notes, input and output
information. It is worth mentioning that there might be variations in the method and frequency of vital
sign data. For the eICU-CRD database, vital signs of periodic monitoring by machine were
automatically interfaced, stored archived with a median interval of five minutes. In the MIMIC-III and
PLAGH-S database, the vital sign values were recorded and confirmed by nurses. The recording
frequency depends on the patient’s disease severity. When the patient’s condition was not stable, the
nurse would record once every 5 to 15 minutes. Otherwise, it was usually recorded once per hour.
Contents in this study involving MIMIC-III and eICU-CRD databases was an analysis of a
third-party anonymized publicly available database with pre-existing institutional review board (IRB)
approval. Contents in this study using PLAGH-S database was approved by the ethics committee of the
General Hospital of PLA (No·S2017-054-01).
Study Population
All ICU patients 65 years old or older with multiple organ dysfunction syndrome, namely existing
over two failure organs according to the sequential organ failure assessment score,24 were included
from three databases. We excluded patients with unknown outcomes, less than 24h of ICU admission
4stay, and secondary or multiple times entering hospital to avoid repeated inclusion. The patients
without heart rate, respiratory rate, mean arterial pressure, glasgow coma score, temperature and
oxygen saturation data in the first 24h ICU admission were also excluded.
Data Extraction
The following seven types of information representing the study cohort’s baseline information
were collected to develop the prediction model: 1) patient characteristics such as age, gender, ethnicity,
diagnosis upon admission using International Classification of Diseases (9th revision); 2) clinical
scores of the first day in ICU, reflecting patient’s diseases severity, including APSIII acute physiology
score III (APSIII)10, OASIS and SOFA scores; 3) vital signs of the first day in ICU, including heart rate,
respiratory rate, and mean arterial pressure, etc.; 4) laboratory results of the first day in ICU, including
glucose, creatinine, white blood cell count, and bilirubin level, etc.; 5) the fluid input and urine output
recorded in the first day in ICU; 6) the clinical treatments received during the first day in ICU,
including mechanical ventilation, continuous renal replacement therapy and vasopressors usage; 7)
in-hospital outcomes including mortality, duration of hospital and ICU stay. Table 1 presents an
overview of the extracted information from each database. Detailed description is provided in the
online supplementary files.
Table 1: Information extracted from three databases involved in this study
Types Contents
Demographic
(18)
Age, gender, ethnicity, admission type, ICU admission unit, height, weight, chronic liver failure
(CLF), acute liver failure (ALF), chronic obstructive pulmonary disease (COPD), acute
respiratory distress syndrome (ARDS), coronary artery disease (CAD), chronic renal failure
(CRF), acute renal failure (AKI), chronic heart failure (CHF), acute heart failure (AHF), stroke,
and malignancy
Clinical scores (6) APSIII, OASIS, SOFA, MODS, Systemic inflammatory response syndrome (SIRS) and GCS
Vital signs
(8)
Heart rate (HR), respiratory rate (RR), mean arterial pressure (MAP), systolic blood pressure
(SBP), diastolic blood pressure (DBP), central venous pressure (CVP), temperature (T) and
oxygen saturation (SpO2)
Laboratory tests
(32)
Albumin, alkaline phosphatase, alanine transaminase (ALT), ast aspartate transaminase (AST),
base excess (BE), prothrombin time (PT), partial thromboplastin time (PTT), bicarbonate,
bilirubin, brain natriuretic peptide (BNP), BUN, chloride, creatinine, fibrinogen, glucose,
hematocrit, hemoglobin, international normalized ratio (INR), lactate, lymphocytes, magnesium,
neutrophils, partial pressure of oxygen (PaO2), fraction of inspired oxygen (FiO2), partial
pressure of carbon dioxide in arterial blood (PaCO2), PaO2/FiO2 ratio, ph, platelet, potassium,
sodium, troponin, and white blood cell (WBC)
Output (1) Urine output (UO)
Treatments
(6)
Mechanical ventilation (vent), continuous renal replacement therapy (CRRT), vasopressors
usage of dobutamine, dopamine, epinephrine, and norepinephrine
Outcomes (3) Hospital outcome, days of hospital stay, and days of ICU stay
5Feature Selection
According to the initial data from three databases, we further dug more information to represent
patients’ diseases severity. Based on the seven types of records, the statistical features of maximum
(max), minimum (min), average (avg), sum and mapping to ‘Yes/No’ were calculated by the extracted
data expecting patient characteristics data. For the type of vital signs, the max, min and avg were
entirely calculated of each sub-term; For the type of laboratory tests, only the max and min were
obtained of each sub-term; For the type of treatment, vent, CRRT and vasopressors of dobutamine were
represented by flag indicating whether a patient has received the corresponding treatment, and the max
rate flow of other vasopressors were obtained for more specific information; For the type of output,
urine output of the first 3, 6, 12 and 24 hours staying in ICU were acquired. Missing data was
processed as follows: Missing values were imputed using the median value of each feature except for
FiO2 (with the imputation of 21%). Additionally, for the proportions of missing part greater than 30%,
flag indication of whether a record existing was produced as new features. Finally, a total of 130
features were constructed. Additional information can be found in the supplementary materials. The
proportions of missing raw data and details of the features are presented in supplementary eTable 4.
Statistical Analysis
All continuous variables including clinical scores were reported as medians with 25th and 75th
interquartile ranges. The t test or Wilcoxon rank sum test was used when appropriate to compare
between surviving and non-surviving elderly with MODS. Categorical variables were calculated to
obtain the total number and percentage. P values (two sides) less than 0·05 was considered statistically
significant.
Model Development
The eXtreme Gradient Boosting model (XGBoost) was employed for early assessment of patients’
risk of death in hospital.25 It’s a machine learning algorithm with high computational speed and
satisfactory prediction performance, due to its improvements of tree boosting in ensemble technique.
Thousands of decision trees, weak learners generated with this method, are composed into strong
learners using gradient boosting approach to iteratively train and optimize the parameters. In order to
get a universal and robust prediction model, we explored the impact of different types of data sources
on model performance. Considering the small samples size of the PLAGH-S cohort, it was suitable as a
test set for evaluation. Therefore, we employed three models displayed in Figure 1. Model 1 was
developed using 80% of a cohort randomly selected from the MIMIC-III database, which represented a
single center database. Model 2 was developed from the eICU-CRD database using the same methods,
which results in cohorts of patients from multiple centers. Model 3 was developed from the combined
data from Models 1 and 2, which comprised a larger sample size and longer time span. For each model,
the cross-validation process was not carried out in this paper owing to its large sample sets. We chose
‘AUC’ as the model’s evaluation metric to reduce the bias of class imbalance. The important
hyperparameters were set to default values, including the learning rate (learning_rate = 0·1), the
maximum depth of each tree (max_depth = 3) and the numbers of modeling sequential trees
(n_estimators = 100).
6Figure 1: The process of developing the optimal prediction model
Model Evaluations
We obtained the three cohorts as testing sets from MIMIC-III (20% of data), eICU-CRD (20% of
data) and PLAGH-S (all of data). Detailed analyses to assess the models’ performances in different data
sources were conducted, including internal and external validations, comparisons of baseline models
and clinical scores (five machine learning methods: logistic regression (LR), support vector machine
(SVM), neural network (NN), random forests (RF) and naive bayesian (NB); and five commonly used
scores: SOFA, MODS, SAPS, OASIS and APSIII). The evaluation indexes included AUC, sensitivity,
specificity, accuracy and F1 score.
Model interpretation
SHAP (SHapley Additive exPlanations) is a novel approach to explain various black box machine
learning models, which had been validated in its interpretability performance and had been proven
helpful for anesthesiologists to identify hypoxaemia during surgery.26,27 The method defines the
Shapley value as the only indicator to evaluate a feature’s effect and adopts three properties with local
accuracy, missingness and consistency to measure the feature’s importance.28 We leveraged it to
provide the interpretation of our early prediction model with contributing risk factors leading to death
in elderly patients with MODS.
The data extraction was accomplished with PostgreSQL Version 9·6. All calculations and analyses
were performed utilizing Python Version 3·7·1 (the xgboost, sklearn and shap packages) and R Version
3·6·0 (the tableone package).
Results
Patient characteristics
This study included 15,804 elderly patients (2,353 non-survivors) with MODS for analysis in
MIMIC-III cohort. A total of 34,201 (3,966 non-survivors) and 439 (51 non-survivors) patients were
respectively included in eICU-CRD and PLAGH-S cohorts, respectively. Figure 2 shows the inclusion
criteria of three data sources’ cohorts (see the supplementary files eFigure 1 to eFigure 3 for the
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cohorts. The eTable 1 displays the comparison baseline information of survivors and non-survivors in
the MIMIC-III study cohort. The non-survivors were significantly older in age and had higher severity
scores and lower BMI upon ICU admission. Incidence of comorbidities such as COPD, AHF and CRF
were not significantly different between the two groups. Duration of ICU stay was longer among
non-survivors while duration of hospital stay was shorter among them. The patient characteristics of
the eICU-CRD cohort was similar to MIMIC-III’s (eTable 2), except the comorbidities were slightly
different. Limited by the small size of the sample set, only differences in days of hospital/ ICU stay and
severity scores of APSIII/ SOFAwere consistent to the counterparts in PLAGH-S cohort (eTable 3).
Figure 2: An overview of inclusion criteria with the multicenter study cohorts
Table 2: The comparison of the total study cohorts’ baseline characteristic
MIMIC-III
(n = 15,804)
eICU-CRD
(n = 34,201)
PLAGH-S
(n = 439)
Demographic
Age (yr), (median, IQR) 77·00 [71·00, 83·00] 76·00 [70·00, 83·00] 73·00 [68·00, 79·50]
Male, n (%) 8281 (52·4) 17586 (51·4) 248 (56·5)
Weight (kg), (median, IQR) 77·20 [65·00, 90·70] 77·30 [64·40, 92·00] 65·00 [58·00, 72·00]
Height (cm), (median, IQR) 167·64 [160·02, 175·26] 167·60 [160·00, 177·00] 165·00 [160·00, 172·00]
BMI (kg/m2), (median, IQR) 27·97 [24·37, 32·07] 27·10 [23·30, 31·80] 24·00 [22·00, 27·00]
ICU type (%)
CCU 2738 (17·3) 7077 ( 20·7) ··
CSRU 3509 (22·2) 902 (2·6) ··
MICU 5428 (34·3) 21382 (62·5) ··
NICU ·· 2860 (8·4) ··
SICU 2473 (15·6) 1980 (5·8) 439 (100·0)
TSICU 1656 (10·5) ·· ··
Ethnicity (%)
ASIAN 360 (2·3) 386 (1·1) 439 (100·0)
8BLACK 903 (5·7) 2850 (8·3) ··
HISPANIC 264 (1·7) 1259 (3·7) ··
OTHER/UNKNOWN 2504 (15·8) 1541 (4·5) ··
WHITE 11773 (74·5) 28165 (82·4) ··
Admission type (%)
ELECTIVE 2332 (14·8) 12974 ( 37·9) ··
FLOOR ·· 3400 (9·9) 39 (8·9)
INTERMEDIATE CARE
UNIT
·· 2347 (6·9) ··
OTHER/KNOWN ·· 9627 (28·1) 259 (59·0)
URGENT 466 (2·9) 5853 (17·1) ··
EMERGENCY 13006 (82·3) ·· 141 (32·1)
Comorbidities
CLF 436 ( 2·8) 225 ( 0·7) 8 ( 1·8)
ALF 250 ( 1·6) 58 ( 0·2) 77 (17·5)
COPD 3542 (22·5) 4250 (12·4) 37 ( 8·4)
ARDS 2960 (18·8) 7655 (22·4) 66 (15·0)
CAD 7129 (45·3) 3069 ( 9·0) 181 (41·2)
CRF 2248 (14·3) 3635 (10·6) 31 ( 7·1)
AKI 4165 (26·5) 4514 (13·2) 77 (17·5)
CHF 5418 (34·4) 4391 (12·8) 18 ( 4·1)
AHF 1477 ( 9·4) 263 ( 0·8) 180 (41·0)
Stroke 1265 ( 8·0) 1282 ( 3·8) 62 (14·1)
Malignancy 1413 ( 9·0) 808 ( 2·4) 234 (53·3)
Severity of illness
APSIII 42·00 [33·00, 55·00] 42·00 [29·00, 59·00] 78·00 [55·00, 91·00]
OASIS 34·00 [28·00, 40·00] 32·00 [26·00, 40·00] 31·00 [25·00, 35·00]
SOFA 4·00 [2·00, 6·00] 5·00 [4·00, 8·00] 15·00 [12·00, 17·00]
MODS 5·00 [2·00, 7·00] 3·00 [2·00, 6·00] 13·00 [11·00, 14·00]
SAPS 20·00 [17·00, 23·00] 20·00 [17·00, 24·00] 22·00 [18·00, 24·00]
Outcomes
Days of hospital admission (d),
(median, IQR)
7·88 [5·05, 12·81] 6·32 [3·96, 10·04] 10·71 [7·06, 16·91]
Days of ICU admission (d),
(median, IQR)
2·75 [1·71, 4·99]
2·53 [1·69, 4·14] 3·43 [2·11, 6·72]
Hospital mortality, n (%) 2353 (14·89) 3966 (11·60) 51 (11·62)
BMI body mass index, CCU coronary care unit, CSRU cardiac surgery recovery unit, MICU medical ICU, SICU
surgical ICU, TSICU trauma/surgical ICU.
Development of prediction model
According to Figure 1, three prediction models were obtained from different data sources. The
performance of models was evaluated by the aforementioned parameters (AUC, sensitivity, specificity,
F1 and accuracy) and internal/ external validation. ‘Model 3’ had the best performance using
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and centers. ‘Model 2’ is acquired employing multicenter datasets of the eICU-CRD database, and the
performance of which is not as good as ‘Model1’.
Table 3: Summary of the optimal model’s cross validation performance in multicenter databases
Indexes
Training set
Testing set MIMIC-III eICU-CRD MIMIC-III - eICU-CRD
AUC
MIMIC-III 0·866 0·823 0·858
eICU-CRD 0·837 0·849 0·849
PLAGH-S 0·835 0·811 0·838
Sensitivity
MIMIC-III 0·802 0·774 0·834
eICU-CRD 0·752 0·841 0·763
PLAGH-S 0·725 0·627 0·882
Specificity
MIMIC-III 0·760 0·712 0·705
eICU-CRD 0·772 0·700 0·784
PLAGH-S 0·820 0·858 0·691
F1
MIMIC-III 0·681 0·624 0·664
eICU-CRD 0·676 0·655 0·652
PLAGH-S 0·690 0·722 0·701
Accuracy
MIMIC-III 0·876 0·871 0·875
eICU-CRD 0·891 0·901 0·901
PLAGH-S 0·882 0·900 0·882
AUROC (AUC) Area under the receiver operating characteristic curves, MIMIC-III - eICU-CRD the training set
with the fusion of MIMIC-III’s cohort and eICU-CRD’s cohort
Explanation of risk factors
In order to improve the clinical significance of the model, the following results were obtained:
key risk factors affecting the outcome of elderly patients with MODS and how the factors’ value was
related to the patient outcome; how to visually explain the early predictive risk of a single patient,
which would help doctors understand the analytic process of the prediction model. We adopt ‘Model3’
as our optimal early risk prediction model to assess patient outcome.
Figure 3(a) displays the top 20 risk factors in our model. The features ranking (y axis) implies the
importance of the prediction model. The SHAP value (x axis) is a unified index responding to the
impact of a feature in the model. In each feature importance row, all patients’ attribution to outcome
were plotted using different color dots, in which the red (blue) dot represented high (low) value. Figure
3(b) shows the top 20 most important features evaluated by the average of absolute SHAP value. Risk
factors such as GCS (max, avg and min), Respiratory Rate (rr: avg), Blood Urea Nitrogen (BUN: min),
age, shock index (si: avg), SIRS score (avg), total urine output of 24 hours (uo) and Blood Oxygen
Saturation (SpO2: min) during the initial 24 hours of ICU stay were ranked as the ten most important
factors. The most important feature of GCS is to emphasize the nervous system as the most crucial for
early assessment of patient’s status than other organ systems. BUN level was found to be a key factor,
which is easily overlooked by clinicians. Figure 3(c) provides two typical relative samples to illustrate
the interpretability of the model. Although the patient had normal urine output (2825 ml), BMI (31·4
kg/m2) and SpO2 (98·76 %), he died due to poor GCS (7 points), high BUN (59 mg/dL) and FiO2
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(60 %). While the survivor had normal GCS (15 points), SIRS score (1 point), BUN (9 mg/dL) and no
mechanical ventilation need. Although at very high age (87 years old) and had high blood glucose level
(148 mg/dL), the patient survived after treatment. The risk factor rankings of ‘Model 1’ and ‘Model 2’
can be found in the supplementary files (eFigure 5 and eFigure 6). A summary of three models’ risk
factors ranking was presented in eTable 6. With different training sets, the feature importance rankings
remained largely unchanged, which demonstrated the robustness and stability of the SHAP value
employment to assess risk factors.
Figure 3: The model’s interpretation. (a). The importance ranking of the top 20 risk factors with
stability and interpretation using the optimal model. The higher SHAP value of a feature is given,
the higher risk of death the patient would have. The red part in feature value represents higher
value; (b). The importance ranking of the top 20 variables according to the mean (|SHAP value|);
(c). The interpretation of model prediction results with the two samples
Predictive performance evaluation
The model’s performance validated by using the MIMIC-III cohort is presented in Figure 4 and
summarized in eTable 7. Consistently, our model (AUC with 95% confidence interval (CI): 0·858
[0·841 - 0·875]) was superior to 5 baseline machine learning models and commonly used clinical
scores. The model’s performance evaluated with the eICU-CRD and PLAGH-S cohorts is presented in
the supplementary files (eFigure 8, eTable 8, eFigure 9 and eTable 9). Although the AUC of the our
novel model was slightly lower than that of SVM (eFigure 9), the sensitivity of the model was
significantly better. These results have demonstrated satisfactory predictive ability and universality of
the model. We retained the top 20 features as input values to evaluate the model’s performance when
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multiple features required by the model were not measured or documented.
As shown in eFigure 10, good prediction performance was achieved in three validation datasets
(AUC 0·858 of 130 features vs AUC 0·851 of 20 features using the MIMIC-III cohort, AUC 0·849 of
130 features vs AUC 0·839 of 20 features using the eICU-CRD cohort, AUC 0·838 of 130 features vs
AUC 0·776 of 20 features using the PLAGH-S cohort). Consistently, all results of this model
outperformed all clinical scores listed in eTable 10. The model’s performance when validated
leveraging the total cohort from MIMIC-III and eICU-CRD was presented in eTable 11, which
provides extra information for further evaluation of the model’s performance.
Figure 4: Our model’s performance, evaluated in the MIMIC-III cohort, comparing with the
baseline models and clinical scores
Discussion
In this study, a generalizable and interpretable model for the early prediction of mortality risk in
elderly patients with MODS was developed and validated based on three clinical databases, and
performed well in the early assessment of organ damage, providing crucial support for clinical decision
making. Generally, four part of contributions were accomplished in this study: (1) Comprehensive and
reasonable experiments were designed to establish an optimal prediction model with satisfactory
performance, utilizing training sets from both single center with long time span and multiple centers
with short time span as well as the fusion of both; (2) Multiple methods and indexes were utilized to
evaluate the model’s performance, including internal and external validations covering the countries
with different levels of economic development. Meanwhile, comparisons with machine learning
methods and clinical scores were also included. The indexes adopted were AUC, sensitivity, specificity,
F1, accuracy, robustness and universality; (3) The explanation was employed to the black box tree
ensemble model of XGBoost, which helps doctors better understand the decision-making process of the
model; (4) Key risk factors with robustness and interpretation were acquired. Two important factors of
BUN and shock index, significantly correlated to death, also were discovered, which were commonly
overlooked by physicians and commonly used clinical scores.
Most previous researchers examined the early mortality prediction performance of the proposed
models by cross validation limited to their single-center study dataset. Although their models
performed well in that setting, their performances in other datasets were not verified. In this study, the
model proposed by us was evaluated using large sample-size and multicenter databases, which enabled
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us to accomplish the internal and external validations without overlapping. To the best of our
knowledge, this is the first study in which mortality prediction and assessment models were validated
in countries with different economic development levels (US & China). In order to comprehensively
evaluate the model’s performance, the commonly used clinical scores and machine learning methods
were both included and five measurements were adopted to compare both of them. Moreover, the new
score of OASIS, which had been proven to have more concise inputs and better performance compared
to the APACHE score was also included for comparison.1829 Finally, our model consistently
outperformed all the baseline models and clinical scores (Figure 4, eFigure 8 and eFigure 9). Thus, the
model bears great potential to be generalized and applied in clinical practice.
Several recent studies have reported their models’ validation performance using multicenter
datasets. Matthew MC et al. developed a model using 60% of the data from a multicenter database and
evaluated it using the remaining 40% of the data.29 Shamin N et al. utilized a regional clinical database
to develop the model and externally validated it utilizing a database from another region.30 Benjamin S
et al. adopted their local database to train the model and assessed it with combined internal and external
validations.19 Hamid M et al. leveraged three institutional databases and trained one model from each
institution which was evaluated using databases from the remaining institutions.31 However, these
studies did not specify an approach to get a generalizable and robust model. Thus, we chose the special
validation sets where no overlapping exists among training sets to evaluate the models’ performance
(accuracy and robustness). The validation sets in our study included 20% of the MIMIC-III cohort,
20% of the eICU-CRD cohort and total cohort of the PLAGH-S. Data used for training were the
remaining data from each database, namely MIMIC-III and eICU-CRD, as well as the combination of
them. Therefore, three different types of training sets (single-center with long duration, multicenter
with short duration and the fusion of them) were analyzed and validated, which enabled us to develop
this optimal predictive model.
Recently, interest in using the interpretation and tree ensemble models have been growing to
develop mortality prediction model, such as RF and Gradient Boosting Decision Tree (GBDT).29,32,33
Although tree ensemble models are more accurate compared to LR and can provide features
importance ranking, it cannot tell clinicians whether the important factors are protective or dangerous
like LR dose: the ‘black-box’ nature of machine learning algorithms can make it difficult to understand
and correct errors when they occur.34 Meanwhile, a trade-off between the accuracy and interpretation of
the models is often hard to achieve. In addition, the risk probability output of the model is not easily
understandable for doctors. Therefore, we applied the proposed SHAP values to the XGBoost, which
made our model able to achieve both optimal accuracy and interpretability to provide more insights to
doctors. Detailed information was described in results, as well as explanation of risk factors. In
summary, given the key risk factors, the model can visually explain to clinicians which specific
features of elderly patients with MODS predispose them to high (low) risk of death.
Most of the current predictive models based on tree (ensemble) methods generate features
important rankings using default parameters of ‘importance type’. Actually, there are five alternative
types available (ie., ‘weight’, ‘gain’, ‘cover’, ‘total_gain’ and ‘total_cover’) and the ranking results
would be changed when different types were chosen. Top 30 features ranking results in three
commonly used types were illustrated in eFigure 14. and eTable 8, which intuitively presented its
inconsistency. Different from the previous studies, we adopted the SHAP value, a unified measure,
while generating features important ranking. It had been theoretically proven to be an optimal approach
and the only possible consistent feature attribution method.28 Its consistency has been proved with the
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similar feature ranking even though using the multiple sources of training data in as shown in eTable 9.
The key risk factors identified in this study are consistent with clinicians’ prior knowledge. Two
statistically significant factors identified, BUN and shock index, ranked fourth and sixth, respectively,
were usually overlooked by physicians and contributed in mortality assessment in elderly with MODS.
BUN is a laboratory test used to evaluate renal function, a high value of which might be related to renal
failure, hypovolemia, congestive heart failure and increased catabolism, etc. However, most of the
clinical scores (like SOFA, APACHE-II) only include creatinine level. Recently, several studies found
BUN to be an independent factor (biomarker) for mortality in ICU patients, and that it can also indicate
the degree of heart failure by reflecting the interaction of nutrition, protein metabolism and renal
status.35,36 Okan A et al. found that high BUN level to be indicative of ongoing multi-organ failure.36
While these studies are limited by small sample sets and utilization of early simplified models, results
of our study were based on the large sample sets and sophisticated models. Ryan W. H et al. recently
reported that persistent elevation of BUN indicates concurrent muscle bioenergetic failure, muscle
catabolism/altered protein homeostasis and persistent muscle loss, which further affects the metabolic
process and aggravates disease severity.37 Shock index was generally utilized to measure the severity of
sepsis and septic shock.38 Some studies also demonstrate it to be a mortality predictor or indicator for
certain kinds of diseases.39,40 As for elderly patients suffering from multiple organ dysfunction, our
results indicate that shock index could be used as an important factor to predict patient death. Before
the study, we speculated that a large proportion of the patients in the dataset would have sepsis or septic
shock. Consistently, the sepsis population ratio and its death rate for each study cohort were relatively
high (47·08% of sepsis and 8·53% of mortality in the MIMIC-III cohort, 63·60% of sepsis and 9·47%
of mortality in the MIMIC-III cohort, and 59·68% of sepsis and 8·89% of mortality in the MIMIC-III
cohort). A more in-depth investigation of the disease mechanism warrants further studies.
Interestingly, two risk factors, GCS (nervous system) and respiratory rate (respiratory system),
ranking No. 1 and 3 respectively, were found to be critical in assessing disease severity, which is
consistent to the conclusion of a previous study.19 This finding indicates that the state of the nervous
and respiratory systems should be paid more attention to, rather than being treated equally as other
systems. For a more comprehensive assessment of our model’s robustness, we selected the top 20
features acquired by SHAP values to train the model, which were evaluated in three study cohorts.
Consequently, our model achieved satisfactory performance which outperforms all the commonly used
clinical scores.
This study has some limitations. Although the predictive model in this study achieved early
mortality prediction in elderly patients with MODS, it would be of greater value to accomplish a
real-time evaluation of disease severity. Therefore, we plan to leverage the time series models such as
long short-term memory (LSTM) to develop real-time prediction models. Moreover, the PLAGH-S
database was constructed to facilitate the management of surgical ICU data in our hospital, which is a
single ICU dataset compared to the MIMIC-III and eICU-CRD database where all types of ICU wards
are included. We evaluated the model using the PLAGH-S’ cohort, which failed to accurately reflect
the performance of the model. Therefore, we will further complete data standardization and sort out the
cohort from the PLAGH General Intensive Care Unit Database, which contains the hospitalization
records of above 66,227 adult patients in nine ICUs in the past ten years. This will allow us to provide
readers with more accurate multicenter validation results in different countries.
In conclusion, based on the multicenter clinical databases originating from different regions, we
established a generalized and interpretable predictive model with optimal performance utilizing the
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fusion data of the MIMIC-III and eICU-CRD cohorts for early evaluation of mortality risk in elderly
with MODS. The top ten risk factors with the greatest predictive value are GCS, respiratory rate, BUN,
age, shock index, SIRS score, total urine output on the first day in ICU and SpO2. Meanwhile, BUN
and shock index are factors worth more attention from clinicians for their predictive value of mortality
in elderly patients with organ dysfunction.
Code and data available
The code that was used to extract code from the MIMIC-III and eICU-CRD databases, develop
machine learning models and calculate statistical analysis and part of source data are available at
https://github.com/liuxiaoliXRZS/MODSE.
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Additional Methods
Additional Reference
eFigure 1: Study cohort in the MIMIC-III database. Detailed inclusion with the number of cohorts were
indicated
eFigure 2: Study cohort in the eICU-CRD database. Detailed inclusion with the number of cohorts
were indicated
eFigure 3: Study cohort in the PLAGH-S database. Detailed inclusion with the number of cohorts were
indicated
eFigure 4: The importance ranking of top 30 risk factors utilizing the custom methods
eFigure 5: The importance ranking of the top 20 risk factors with stability and interpretation employing
the MIMIC-III cohort
eFigure 6: The importance ranking of the top 20 risk factors with stability and interpretation employing
the eICU-CRD cohort
eFigure 7: The relationship between the risk factors and death with the top 6. In each subgraph, the
most correlation feature with this risk factor also be presented
eFigure 8: Our model’s performance, evaluated in the eICU-CRD cohort, comparing with the baseline
models and clinical scores
eFigure 9: Our model’s performance, evaluated in the PLAGH-S cohort, comparing with the baseline
models and clinical scores
eFigure 10: The cross-validation of our model with the top 20 importance risk factors in the
multi-center databases
eTable 1: Baseline characteristic of the patients be included in the MIMIC-III cohort
eTable 2: Baseline characteristic of the patients be included in the eICU-CRD cohort
eTable 3: Baseline characteristic of the patients be included in the PLAGH-S cohort
eTable 4: The features’ missing ratio before being processed
eTable 5: The variables information of top 30 risk factors utilizing the custom methods
eTable 6: The variables information of top 20 risk factors with prediction models developing by
different databases
eTable 7: The detailed information of the optimal model’s performance evaluated in the MIMIC-III
cohort
eTable 8: The detailed information of the optimal model’s performance evaluated in the eICU-CRD
cohort
eTable 9: The detailed information of the optimal model’s performance evaluated in the PLAGH-S
cohort
eTable 10: The detailed information of our model’s performance with cross-validation in the
multicenter databases
eTable 11: The additional information of cross-validation leveraging the total cohorts as the testing set
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Additional Methods
Data extraction
Data was separately extracted and limited to the first 24h for patients staying in ICU from three
databases adopting Postgresql language. The static information (ie. demographic) were directly
extracted and named according to their meaning. The dynamic information (ie. vital signs, laboratory
measurement, output and clinical treatment) were totally extracted. Due to the 208 critical care units
included in eICU-CRD database, the critical care units’ name and admission type of patients were
inconsistently recorded. Therefore, the types of ICU were categorized as ‘CSRU’, ‘SICU’, ‘CCU’,
‘MICU’, ‘NICU’ or ‘other/Unknown’, and the types of admission were categorized as ‘URGENT’,
‘EMERENCY’, ‘FLOOR’, ‘Intermediate Care Unit’ or ‘Other/Unknown’. Moreover, only the clinical
score of APS-III was recorded in eICU-CRD database. Therefore, the other clinical scores were
calculated for each study cohort according to the definition.
Feature selection
Before further calculating the statistical features, we dropped the outliers of them using the range
of features that have been obtained. Firstly, the initial values expected base excess were received
logarithmic transformation and the interquartile range (IQR) method was adopted to get the lower and
upper bound which should be further calculated to get the inverse of logarithm bounds. Then, the
clinician helped us listing the physiological boundaries of each feature. Finally, both considering the
two ways, we acquired the final utilizing boundaries. The missing values of the feature were imputed
using the median value. While the missing values of FiO2 were imputed to 21. Moreover, the feature
missing ratio exceeding 30% was added additional information to indicate whether it was being
measured. And we used ‘flag’ (with the imputation of ‘0’ or ‘1’) to represent them indicating whether it
be or not be recorded. In order to uniformly each of feature’s name in three study cohorts, we called
them using the features’ abbreviation with the add of statistical or flag name, like ‘hr_min’,
‘lactate_max’ and ‘dobutamine_flag’, which was convenient for subsequent comparative analysis.
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eFigure 1: Study cohort in the MIMIC-III database. Detailed inclusion with the number of
cohorts were indicated
eFigure 2: Study cohort in the eICU-CRD database. Detailed inclusion with the number of
cohorts were indicated
21
eFigure 3: Study cohort in the PLAGH-S database. Detailed inclusion with the number of cohorts
were indicated
eTable 1: Baseline characteristic of the patients be included in the MIMIC-III cohort
All Patients
(n = 15804)
Survivors
(n = 13451)
Non-survivors
(n = 2353)
p
Demographic
Age (yr), (median, IQR) 77·00 [71·00, 83·00] 77·00 [71·00, 83·00] 79·00 [73·00, 85·00] <0·001
Male, n (%) 8281 (52·4) 7108 (52·8) 1173 (49·9) 0·008
Weight (kg), (median, IQR) 77·20 [65·00, 90·70] 78·10 [65·80, 91·40] 73·10 [61·00, 86·00] <0·001
Height (cm), (median, IQR) 167·64 [160·02, 175·26] 167·64 [160·02, 175·26] 166·37 [160·00, 175·26] 0·006
BMI (kg/m2), (median, IQR) 27·97 [24·37, 32·07] 28·11 [24·58, 32·22] 26·87 [23·08, 31·18] <0·001
ICU type (%) <0·001
CCU 2738 (17·3) 2373 (17·6) 365 (15·5)
CSRU 3509 (22·2) 3331 (24·8) 178 (7·6)
MICU 5428 (34·3) 4373 (32·5) 1055 (44·8)
SICU 2473 (15·6) 2014 (15·0) 459 (19·5)
TSICU 1656 (10·5) 1360 (10·1) 296 (12·6)
Ethnicity (%) <0·001
ASIAN 360 (2·3) 300 (2·2) 60 (2·5)
BLACK 903 (5·7) 800 (5·9) 103 (4·4)
HISPANIC 264 (1·7) 227 (1·7) 37 (1·6)
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OTHER 2504 (15·8) 2014 (15·0) 490 (20·8)
WHITE 11773 (74·5) 10110 (75·2) 1663 (70·7)
Admission type (%) <0·001
ELECTIVE 2332 (14·8) 2244 (16·7) 88 (3·7)
EMERGENCY 13006 (82·3) 10808 (80·4) 2198 (93·4)
URGENT 466 (2·9) 399 (3·0) 67 (2·8)
Comorbidities
CLF 436 ( 2·8) 317 ( 2·4) 119 (5·1) <0·001
ALF 250 ( 1·6) 115 ( 0·9) 135 (5·8) <0·001
COPD 3542 (22·5) 2964 (22·1) 578 ( 24·8) 0·005
ARDS 2960 (18·8) 1925 (14·4) 1035 ( 44·3) <0·001
CAD 7129 (45·3) 6330 (47·2) 799 ( 34·2) <0·001
CRF 2248 (14·3) 1902 (14·2) 346 ( 14·8) 0·446
AKI 4165 (26·5) 3085 (23·0) 1080 ( 46·3) <0·001
CHF 5418 (34·4) 4515 (33·7) 903 ( 38·7) <0·001
AHF 1477 ( 9·4) 1280 ( 9·6) 197 (8·4) 0·095
Stroke 1265 ( 8·0) 857 ( 6·4) 408 ( 17·5) <0·001
Malignancy 1413 ( 9·0) 1051 ( 7·8) 362 ( 15·5) <0·001
Severity of illness
APSIII 42·00 [33·00, 55·00] 41·00 [32·00, 51·00] 57·00 [43·00, 75·00] <0·001
OASIS 34·00 [28·00, 40·00] 33·00 [28·00, 38·00] 40·00 [35·00, 47·00] <0·001
SOFA 4·00 [2·00, 6·00] 4·00 [2·00, 6·00] 6·00 [3·00, 9·00] <0·001
MODS 5·00 [2·00, 7·00] 4·00 [2·00, 7·00] 6·00 [4·00, 10·00] <0·001
SAPS 20·00 [17·00, 23·00] 19·00 [16·00, 22·00] 22·00 [19·00, 26·00] <0·001
Outcomes
Days of hospital admission (d),
(median, IQR)
7·88 [5·05, 12·81] 7·94 [5·24, 12·73] 7·01 [3·28, 13·66] <0·001
Days of ICU admission (d),
(median, IQR)
2·75 [1·71, 4·99] 2·57 [1·66, 4·50] 4·17 [2·06, 8·19] <0·001
eTable 2: Baseline characteristic of the patients be included in the eICU-CRD cohort
All Patients
(n = 34201)
Survivors
(n = 30235)
Non-survivors
(n = 3966)
p
Demographic
Age (yr), (median, IQR) 76·00 [70·00, 83·00] 76·00 [70·00, 83·00] 78·00 [71·00, 84·00] <0·001
Male, n (%) 17586 (51·4) 15551 (51·4) 2035 (51·3) 0·898
Weight (kg), (median, IQR) 77·30 [64·40, 92·00] 77·60 [64·90, 92·30] 75·10 [62·10, 89·90] <0·001
Height (cm), (median, IQR) 167·60 [160·00, 177·00] 167·60 [160·00, 177·00] 167·60 [160·00, 175·30] 0·414
BMI (kg/m2), (median, IQR) 27·10 [23·30, 31·80] 27·20 [23·40, 31·90] 26·40 [22·60, 31·20] <0·001
ICU type (%) <0·001
CCU 7077 ( 20·7) 6380 ( 21·1) 697 ( 17·6)
CSRU 902 (2·6) 769 (2·5) 133 (3·4)
MICU 21382 (62·5) 18721 ( 61·9) 2661 ( 67·1)
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NICU 2860 (8·4) 2573 (8·5) 287 (7·2)
SICU 1980 (5·8) 1792 (5·9) 188 (4·7)
Ethnicity (%) 0·25
ASIAN 386 (1·1) 349 (1·2) 37 (0·9)
BLACK 2850 (8·3) 2539 (8·4) 311 (7·8)
HISPANIC 1259 (3·7) 1128 (3·7) 131 (3·3)
OTHER/UNKNOWN 1541 (4·5) 1366 (4·5) 175 (4·4)
WHITE 28165 (82·4) 24853 ( 82·2) 3312 (83·5)
Admission type (%) <0·001
ELECTIVE 12974 ( 37·9) 11342 ( 37·5) 1632 ( 41·1)
FLOOR 3400 (9·9) 2849 (9·4) 551 (13·9)
INTERMEDIATE CARE UNIT 2347 (6·9) 2066 (6·8) 281 (7·1)
OTHER/KNOWN 9627 (28·1) 8589 ( 28·4) 1038 (26·2)
URGENT 5853 (17·1) 5389 ( 17·8) 464 (11·7)
Comorbidities
CLF 225 ( 0·7) 174 ( 0·6) 51 (1·3) <0·001
ALF 58 ( 0·2) 38 ( 0·1) 20 (0·5) <0·001
COPD 4250 (12·4) 3720 (12·3) 530 ( 13·4) 0·063
ARDS 7655 (22·4) 5923 (19·6) 1732 ( 43·7) <0·001
CAD 3069 ( 9·0) 2684 ( 8·9) 385 (9·7) 0·094
CRF 3635 (10·6) 3104 (10·3) 531 ( 13·4) <0·001
AKI 4514 (13·2) 3528 (11·7) 986 ( 24·9) <0·001
CHF 4391 (12·8) 3781 (12·5) 610 ( 15·4) <0·001
AHF 263 ( 0·8) 217 ( 0·7) 46 (1·2) 0·004
Stroke 1282 ( 3·8) 1087 ( 3·6) 195 (4·9) <0·001
Malignancy 808 ( 2·4) 664 ( 2·2) 144 (3·6) <0·001
Severity of illness
APSIII 42·00 [29·00, 59·00] 41·00 [28·00, 55·00] 64·00 [45·00, 89·00] <0·001
OASIS 32·00 [26·00, 40·00] 31·00 [25·00, 38·00] 41·00 [34·00, 49·00] <0·001
SOFA 5·00 [4·00, 8·00] 5·00 [4·00, 7·00] 8·00 [6·00, 11·00] <0·001
MODS 3·00 [2·00, 6·00] 3·00 [2·00, 5·00] 7·00 [4·00, 10·00] <0·001
SAPS 20·00 [17·00, 24·00] 20·00 [17·00, 23·00] 25·00 [21·00, 30·00] <0·001
Outcomes
Days of hospital admission (d),
(median, IQR)
6·32 [3·96, 10·04] 6·44 [4·08, 10·06] 5·25 [2·77, 9·78] <0·001
Days of ICU admission (d),
(median, IQR)
2·53 [1·69, 4·14] 2·43 [1·67, 3·98] 3·35 [1·89, 6·46] <0·001
eTable 3: Baseline characteristic of the patients be included in the PLAGH-S cohort
All Patients
(n = 439)
Survivors
(n = 388)
Non-survivors
(n = 51)
p
Demographic
Age (yr), (median, IQR) 73·00 [68·00, 79·50] 73·00 [68·00, 79·00] 73·00 [66·50, 81·50] 0·911
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Male, n (%) 248 (56·5) 220 (56·7) 28 (54·9) 0·926
Weight (kg), (median, IQR) 65·00 [58·00, 72·00] 65·00 [60·00, 73·00] 60·00 [53·00, 69·00] 0·006
Height (cm), (median, IQR) 165·00 [160·00, 172·00] 165·00 [160·00, 172·00] 166·00 [159·50, 172·00] 0·868
BMI (kg/m2), (median, IQR) 24·00 [22·00, 27·00] 24·00 [22·00, 27·00] 23·00 [20·00, 26·00] 0·02
ICU type (%)
SICU 439 (100·0) 388 (100·0) 51 (100·0)
Ethnicity (%)
ASIAN 439 (100·0) 388 (100·0) 51 (100·0)
Admission type (%) 0·006
EMERGENCY 141 (32·1) 122 (31·4) 19 (37·3)
OTHER/UNKNOWN 259 (59·0) 237 (61·1) 22 (43·1)
OUTPATIENT 39 (8·9) 29 (7·5) 10 (19·6)
Comorbidities
CLF 8 ( 1·8) 7 ( 1·8) 1 (2·0) 1
ALF 77 (17·5) 56 (14·4) 21 ( 41·2) <0·001
COPD 37 ( 8·4) 23 ( 5·9) 14 ( 27·5) <0·001
ARDS 66 (15·0) 42 (10·8) 24 ( 47·1) <0·001
CAD 181 (41·2) 160 (41·2) 21 ( 41·2) 1
CRF 31 ( 7·1) 22 ( 5·7) 9 ( 17·6) 0·004
AKI 77 (17·5) 55 (14·2) 22 ( 43·1) <0·001
CHF 18 ( 4·1) 16 ( 4·1) 2 (3·9) 1
AHF 180 (41·0) 136 (35·1) 44 ( 86·3) <0·001
Stroke 62 (14·1) 49 (12·6) 13 ( 25·5) 0·023
Malignancy 234 (53·3) 209 (53·9) 25 ( 49·0) 0·615
Severity of illness
APSIII 78·00 [55·00, 91·00] 77·00 [53·75, 91·00] 88·00 [75·50, 106·50] <0·001
OASIS 31·00 [25·00, 35·00] 32·00 [25·00, 35·00] 31·00 [27·50, 36·00] 0·554
SOFA 15·00 [12·00, 17·00] 14·00 [12·00, 16·00] 18·00 [14·00, 19·00] <0·001
MODS 13·00 [11·00, 14·00] 13·00 [11·00, 14·00] 15·00 [11·00, 17·00] 0·002
Outcomes
Days of hospital admission (d),
(median, IQR)
10·71 [7·06, 16·91] 10·13 [6·86, 15·08] 20·98 [8·92, 37·29] <0·001
Days of ICU admission (d),
(median, IQR)
3·43 [2·11, 6·72] 3·15 [2·03, 5·90] 7·28 [4·21, 20·98] <0·001
eTable 4: The features’ missing ratio before being processed
Features’ name MIMIC-III (%) eICU-CRD (%) PLAGH-S (%)
Demographic
age 0 0 0
bmi 52·73 1·14 7·97
gender 0 0 0
height 36·08 1·13 0
weight 29·35 0·39 7·97
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Laboratory test
albumin_max 64·57 40·22 0·23
albumin_min 64·57 40·22 0·23
alkaline_phosphatase_max 58·96 43·69 0·23
alkaline_phosphatase_min 58·96 43·69 0·23
alt_max 58·03 42·93 0·23
alt_min 58·03 42·93 0·23
ast_max 58·09 41·97 0·46
ast_min 58·09 41·97 0·46
be_max 32·3 61·97 0
be_min 32·3 61·97 0
bicarbonate_max 0·8 9·25 0
bicarbonate_min 0·8 9·25 0
bilirubin_max 58·49 43·68 0·23
bilirubin_min 58·49 43·68 0·23
bnp_max 94·99 85·1 0·46
bnp_min 94·99 85·1 0·46
bun_max 0·28 3·58 0·23
bun_min 0·28 3·58 0·23
chloride_max 0·58 3·66 0·23
chloride_min 0·58 3·66 0·23
creatinine_max 0·24 3·19 0·23
creatinine_min 0·24 3·19 0·23
fibrinogen_max 75·15 91·8 0·46
fibrinogen_min 75·15 91·8 0·46
glucose_max 0·27 1·48 0
glucose_min 0·27 1·48 0
hematocrit_max 0·28 3·36 0·23
hematocrit_min 0·28 3·36 0·23
hemoglobin_max 0·49 3·62 0
hemoglobin_min 0·49 3·62 0
inr_max 8·15 41·06 0·46
inr_min 8·15 41·06 0·46
lactate_max 40·56 60·88 0
lactate_min 40·56 60·88 0
lymphocytes_max 49·73 30·76 0·23
lymphocytes_min 49·73 30·76 0·23
magnesium_max 5·16 38·27 0·23
magnesium_min 5·16 38·27 0·23
neutrophils_max 49·51 37·48 0·23
neutrophils_min 49·51 37·48 0·23
paco2_max 32·3 52·57 0
paco2_min 32·3 52·57 0
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pafi_max 49·27 62·69 0
pafi_min 49·27 62·69 0
pao2_max 32·3 52·29 0
pao2_min 32·3 52·29 0
ph_max 32·3 53·02 0
ph_min 32·3 53·02 0
platelet_max 0·61 4·3 0·23
platelet_min 0·61 4·3 0·23
potassium_max 0·18 2·67 0·23
potassium_min 0·18 2·67 0·23
pt_max 8·18 43·05 0·46
pt_min 8·18 43·05 0·46
ptt_max 8·43 57·03 0·46
ptt_min 8·43 57·03 0·46
sodium_max 0·25 3·44 0·23
sodium_min 0·25 3·44 0·23
troponin_max 66·31 92·16 0·46
troponin_min 66·31 92·16 0·46
wbc_max 0·89 4·39 0·23
wbc_min 0·89 4·39 0·23
Vital sign
cvp_max 62·55 82·64 45·79
cvp_mean 62·55 82·64 45·79
cvp_min 62·55 82·64 45·79
dbp_max 0 0 0
dbp_mean 0 0 0
dbp_min 0 0 0
fio2_max 51·44 55·72 23·46
fio2_min 51·44 55·72 23·46
gcs_max 0 0 0
gcs_mean 0 0 0
gcs_min 0 0 1·14
hr_max 0·03 0·01 0
hr_mean 0·03 0·01 0
hr_min 0·03 0·01 0
map_max 0 0 0
map_mean 0 0 0
map_min 0 0 0
rr_max 0 0 0
rr_mean 0 0 0
rr_min 0 0 0
sbp_max 0 0 0
sbp_mean 0 0 0
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sbp_min 0 0 0
si_max 0·13 0·33 0
si_mean 0·13 0·33 0
si_min 0·13 0·33 0
spo2_max 0·04 0 0
spo2_mean 0·04 0 0
spo2_min 0·04 0 0
t_max 0·09 0·02 0
t_mean 0·09 0·02 0
t_min 0·09 0·02 0
Clinical
dobutamine_flag 0 0 0
rate_dopamine_max 0 0 0
rate_epinephrine_max 0 0 0
rate_norepinephrine_max 0 0 0
vent_flag 0 0 0
crrt_flag 0 0 0
sirs_max 0 0 0
sirs_mean 0 0 0
sirs_min 0 0 0
sofa_neur_max 0 0 0
sofa_neur_mean 0 0 0
sofa_neur_min 0 0 0
sofa_resp_max 0 0 0
sofa_resp_mean 0 0 0
sofa_resp_min 0 0 0
uo_12hour 3·83 31·1 4·1
uo_24hour 3·12 22·99 4·1
uo_3hour 30·81 57·48 6·15
uo_6hour 9·67 43·63 5·01
alt alanine transaminase, ast aspartate transaminase , be the base excess, pafi PaO2/FiO2 ratio, pt the prothrombin time , ptt the
partial thromboplastin time, si shock index, vent mechanical ventilation, crrt continuous renal replacement therapy, uo urine
outout - sofa_neur explain
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eFigure 4: The importance ranking of top 30 risk factors utilizing the custom methods
eTable 5: The variables information of top 30 risk factors utilizing the custom methods
Weight Gain Cover
gcs_max gcs_max gcs_max
rr_mean gcs_mean si_mean
gcs_mean lactate_min pao2_flag
uo_24hour si_mean gcs_mean
si_mean sirs_mean pao2_max
t_min rate_norepinephrine_max bun_min
spo2_mean pao2_flag dbp_min
glucose_min ast_max sirs_mean
bun_min bun_max bun_max
t_mean map_min rr_mean
age creatinine_max magnesium_max
gcs_min bun_min lymphocytes_min
platelet_min rr_mean creatinine_max
chloride_max inr_min chloride_max
bun_max lactate_max age
t_max bicarbonate_min rate_norepinephrine_max
rate_norepinephrine_max si_max spo2_min
bmi cvp_max hr_min
sbp_mean pao2_max lactate_min
weight creatinine_min alkaline_phosphatase_max
alkaline_phosphatase_min ph_flag platelet_min
spo2_min lymphocytes_max ast_max
lymphocytes_max uo_24hour gcs_min
fio2_min dbp_min t_max
rr_min spo2_min vent_flag
wbc_min fio2_min bmi
lactate_min t_mean map_min
albumin_max troponin_max t_mean
ast_max t_max fio2_min
ptt_max t_min lymphocytes_max
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eFigure 5: The importance ranking of the top 20 risk factors with stability and interpretation
employing the MIMIC-III cohort
eFigure 6: The importance ranking of the top 20 risk factors with stability and interpretation
employing the eICU-CRD cohort
eTable 6: The variables information of top 20 risk factors with prediction models developing by
different databases
MIMIC-III eICU-CRD MIMIC-III - eICU-CRD
gcs_max gcs_mean gcs_max
uo_24hour gcs_max gcs_mean
rr_mean rr_mean rr_mean
bun_min spo2_min bun_min
gcs_mean vent_flag age
pao2_flag gcs_min si_mean
spo2_min age sirs_mean
age uo_24hour gcs_min
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weight albumin_max uo_24hour
glucose_min bun_max spo2_min
bun_max si_mean vent_flag
cvp_max fio2_min bun_max
lymphocytes_max hr_mean spo2_mean
sbp_mean bun_min bmi
sirs_min glucose_min glucose_min
si_mean map_min pao2_flag
wbc_min t_min lactate_min
lactate_min ast_max dbp_min
sbp_min wbc_min ast_min
gcs_min lactate_min pao2_max
eTable 7: The detailed information of the optimal model’s performance evaluated in the
MIMIC-III cohort
AUC (95% CI) Sensitivity Specificity
Machine learning model
XGBoost (Our model) 0·858 (0·841 - 0·875) 0·834 0·705
LR 0·854 (0·838 - 0·871) 0·845 0·712
NN 0·834 (0·817 - 0·853) 0·784 0·735
SVM 0·824 (0·804 - 0·844) 0·733 0·785
RF 0·788 (0·766 - 0·810) 0·739 0·707
NB 0·741 (0·716 - 0·765) 0·631 0·746
Clinical scores
OASIS 0·752 (0·729 - 0·776) 0·679 0·704
APSIII 0·73 (0·704 - 0·757) 0·655 0·72
MODS 0·694 (0·669 - 0·719) 0·849 0·417
SAPS 0·686 (0·659 - 0·713) 0·494 0·771
SOFA 0·668 (0·639 - 0·697) 0·429 0·838
eFigure 8: Our model’s performance, evaluated in the eICU-CRD cohort, comparing with the
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baseline models and clinical scores
eTable 8: The detailed information of the optimal model’s performance evaluated in the
eICU-CRD cohort
AUC (95% CI) Sensitivity Specificity
Machine learning model
XGBoost (Our model) 0·849 (0·835 - 0·863) 0·763 0·784
LR 0·847 (0·833 - 0·861) 0·84 0·704
NN 0·81 (0·794 - 0·827) 0·674 0·81
SVM 0·82 (0·803 - 0·838) 0·696 0·838
RF 0·784 (0·766 - 0·803) 0·703 0·731
NB 0·785 (0·768 - 0·802) 0·69 0·734
Clinical scores
MODS 0·755 (0·737 - 0·774) 0·693 0·672
SAPS 0·749 (0·73 - 0·768) 0·632 0·751
OASIS 0·742 (0·723 - 0·761) 0·691 0·685
APSIII 0·730 (0·709 - 0·752) 0·669 0·719
SOFA 0·728 (0·708 - 0·748) 0·681 0·676
eFigure 9: Our model’s performance, evaluated in the PLAGH-S cohort, comparing with the
baseline models and clinical scores
eTable 9: The detailed information of the optimal model’s performance evaluated in the
PLAGH-S cohort
AUC (95% CI) Sensitivity Specificity
Machine learning model
SVM 0·840 (0·774 - 0·906) 0·765 0·822
XGBoost (Our model) 0·838 (0·780 - 0·895) 0·882 0·691
LR 0·823 (0·762 - 0·883) 0·784 0·75
RF 0·772 (0·705 - 0·839) 0·863 0·588
NN 0·732 (0·670 - 0·815) 0·667 0·727
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NB 0·631 (0·588 - 0·674) 0·941 0·332
Clinical scores
SAPS 0·738 (0·658 - 0·818) 0·588 0·776
SOFA 0·708 (0·619 - 0·796) 0·529 0·871
APSIII 0·677 (0·595 - 0·759) 0·373 0·892
MODS 0·629 (0·528 - 0·731) 0·529 0·807
OASIS 0·525 (0·437 - 0·614) 0·118 0·99
eFigure 10: The cross-validation of our model with the top 20 importance risk factors in the
multicenter databases (MIMIC-III, eICU-CRD, PALGH-S)
eTable 10: The detailed information of our model’s performance with cross-validation in the
multicenter databases
AUC Sensitivity Specificity
MIMIC-III
Our model 0·858 0·834 0·705
Our model with part of features 0·851 0·795 0·733
OASIS 0·752 0·679 0·704
APSIII 0·730 0·655 0·720
MODS 0·694 0·849 0·417
SAPS 0·686 0·494 0·771
SOFA 0·668 0·429 0·838
eICU-CRD
Our model 0·849 0·763 0·784
Our model with part of features 0·839 0·712 0·814
MODS 0·755 0·693 0·672
SAPS 0·749 0·632 0·751
OASIS 0·742 0·691 0·685
APSIII 0·730 0·655 0·720
SOFA 0·728 0·681 0·676
PLAGH-S
Our model 0·838 0·882 0·691
Our model with part of features 0·776 0·549 0·871
SAPS 0·738 0·588 0·776
SOFA 0·708 0·529 0·871
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eTable 11: The additional information of cross-validation leveraging the total cohorts as the
testing set
Training set
Testing set MIMIC-III eICU-CRD
MIMIC-III
AUC ·· 0·823
Sensitivity ·· 0·774
Specific ·· 0·712
F1 ·· 0·624
Accuracy ·· 0·871
eICU-CRD
AUC 0·837 ··
Sensitivity 0·752 ··
Specific 0·772 ··
F1 0·676 ··
Accuracy 0·891 ··
APSIII 0·677 0·373 0·892
MODS 0·629 0·529 0·807
OASIS 0·525 0·118 0·99
